Table 1 Patient characteristics
Patients (n = 33) | |
|---|---|
Median age (years, range) | 68.0 (49–82) |
Gender | |
Male | 21 (63.6%) |
Female | 12 (36.4%) |
UICC-stage (TNM 7th ed.) | |
IIIA | 14 (42.4%) |
IIIB | 19 (57.6%) |
Histological type | |
Squamous cell carcinoma | 16 (48.5%) |
Adenocarcinoma | 17 (51.5%) |
Smoker status | |
Non-smoker | 8 (24.2%) |
Smoker | 28 (75.8%) |
Chemotherapy | |
Cisplatin/Vinorelbine | 10 (30.3%) |
Carboplatin/Paclitaxel | 23 (69.7%) |
Localisation | |
Periphery | 23 (69.7%) |
Central | 10 (30.3%) |
Left | 16 (48.5%) |
Right | 17 (51.5%) |
Mean total lung dose (Gy) | 15.7 (8.2–24.43) |
Mean V20 | 25.1 (12.0–45.01) |
Mean V30 | 17.3 (6.4–34.27) |